Braxia Scientific (TSE:BRAX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Braxia Scientific Corp. has announced the successful election of its board of directors and the approval of a major asset sale at its recent Annual General and Special Meeting. The company, known for its innovative ketamine treatments for depression, is moving forward with the sale of its assets including the Canadian Rapid Treatment Center of Excellence. This move is part of Braxia’s proposed transaction aimed at enhancing its commitment to mental health treatments.
For further insights into TSE:BRAX stock, check out TipRanks’ Stock Analysis page.